Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5430_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
10 Мб
Скачать
☆
84
Metals in Medicine, Volume 2


         
inorganic (physicochemical traits attributable to their inorganic constituents,
such as metals or semiconductor materials) like metallic nanoparticles like

       
Due to their catalytic and antioxidant capabilities, metal oxide nanoparticles

include iron oxide (Fe
3
O
4

2

2
), ceria (CeO
2
), and
       
  


applications.
6,7
FIGURE 3.1 

     
  
agent. Multidisciplinary teams comprising chemists, pharmacists, biologists,
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
85
-
     
8
    
      
         


   

    

3.2 ZINC: AN ESSENTIAL ELEMENT
     


        
     
     


  
          


          
  


    

9,10
         
     

        

and humans in 1963. Much has been discovered during the past 40 years

https://t.me/med1917
86
Metals in Medicine, Volume 2

-
  

not re-established, other metabolic adjustments occurs.
11
-
        
        
       
         
-
ments.
12
      
       
     
catalysis, energy , paints, textiles, cosmetics, paints, and the healthcare sector
(cancer therapy, drug delivery, gene delivery, antimicrobial application, bio
imaging, bio sensing, etc.).
13




       
structural support, and regulation. It actively takes part in the catalysis and

   -
opment, membrane stability, behavioral response, reproduction, bone




        



14,15
         
compartments to carry out the numerous duties listed above, and there are
    


https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
87

    
      
     

 




16,17
FIGURE 3.2   

In immunological responses, apoptosis, oxidative stress, homeostasis,
        
         

killer (NK) cell activity , and aging.
18
In the body , the skin has the third-largest
https://t.me/med1917
88
Metals in Medicine, Volume 2
-
       
       -
pathica.
19
   





20

  
  

diseases. An innovative idea that has been used in other illnesses is the use
     

       
      
         
 
21
         


per some studies.
22

     
   

     

23
-
ological relevance, biocompatibility, biodegradability, and pro-regeneration
       -


covalent bonds predominate.
24
-

 
4
  
4
.2H
2
    
ZnFe
2
0
4

2
0
4
, and gahnite), carbonates (smithsonite, ZnC0
3
),
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
89
phosphates (Zn
3
(P0
4
)
2
.4H
2
0, hopeite) and silicates (Zn
2
Si0
4
 
Zn
4
Si
2
0
7
(OH)
2
.H
2
  
9
    

TABLE 3.1 
Compounds
of zinc
Formula Uses References
Zinc
gluconate
C
12
H
22
O
14
Zn • 

• 
25–27
Zinc
pyrithione
C
10
H
10
N
2
O
2
S
2
Zn

• 


• -



28,29
Zinc
ricinoleate
C
36
H
66
O
6
Zn • 

30
Zinc stearate C
36
H
70
O
4
Zn • 


31
Zinc nitrate Zn(NO
3
)
2
• It is employed in the lab to create
coordination polymers, although it has
little practical usage on a broad scale.
32
 󰀚
• Used as oral supplementation to reduce

arthritis.
• 
disease.
• 
-
tered orally.
33-35
Zinc
phosphate
Zn
3
(PO
4
)
2
• Used as anticancer agent in breast cancer
therapy.
• 
membranes can reduce irritation brought
on by membrane exposure and reduce

36,37
Zinc
molybdate
MoO
4
Zn • It is used as a corrosion inhibitor. 38
https://t.me/med1917
90
Metals in Medicine, Volume 2
Compounds
of zinc
Formula Uses References
Zinc
chromate
ZnCrO
4
• 
inhaled.
39
Zinc acetate Zn(C
2
H
3
O
2
)
2
• 

ointment, a topical lotion, or in combina-

• It is used as adjunctive therapy in

disease.
40,41
 ZnS
• 

emitters, and electro catalytic.
42
Zinc cyanide Zn(CN)
2
• -
nine dyes.
43
Zinc
peroxide
H
2
O
2
Zn • 


on by a micro aerophilic hemolytic
streptococcus.
• It has been used as a preventative measure


mucous membrane.
44,45
Zinc oxide ZnO
• Paints, creams, cosmetics, glass, cement,




photography, electrostatic copying paper,
-
turing, and as an ultraviolet absorber in

use it.
46
3.3 ZINC OXIDE NANOPARTICLES


       

TABLE 3.1 (Continued)
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
91






       
         
     
          

     
 

             




         -
     
characteristics. Zinc oxide (ZnO) has been designated by the US FDA as a

human toxicity.
47–50

-

 
becoming smaller particles at the nanoscale. On a small scale, this technique
       

molecules using chemical and physical techniques. It is more expedient and

51
Physical techniques comprise ball milling, laser ablation, etching, and
sputtering. Studies conducted by S. Wirunchit et al. used the ball milling

       
https://t.me/med1917
92
Metals in Medicine, Volume 2

52
Another quick and

           

         
nm) submerged in NaOH (0.1 M).
53





54
-


55
FIGURE 3.3 
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
93

groups based on their physical state: liquid phase synthesis and gas phase



2
-
drate (Zn(CH
3
COO)
2
.2H
2
O) as the parent material to create ZnO nanopar-


56

        
K
2
CO
3
and Zn(NO3)
3
-

57


58
Gas phase synthesis comprises aerosol pyrolysis and gas condensation. One



electron microscopy (SEM) revealed that the produced nanoparticles had

59
Another

condensation to create ZnO nanoparticles.
60


 



          


      -

61
-




     


https://t.me/med1917